PG 415058.01 IRID PU PE SL SC STAN-TONE MB-5729 BLUE STAN-TONE MB-29930 INK

AT 20-16 1 Avis Technique – Tri Détectabilité et tri de la solution colorante AVIENT CORPORATION / CESA® IR PE 94000817 dans les centres de tri D E S C R IP TI O N D E L A D E M A N D E GENERALITES Demandeur Avient Corporation Date de la demande 2020 Référence de la solution colorante CESA® IR PE 94000817 Limite max de concentration de la solution colorante 4% DESCRIPTION DE LA SOLUTION COLORANTE Couleur Noire Solution colorante adaptée pour : Emballages rigides en PE OBJET DE LA DEMANDE Etude de la détectabilité dans les centres de tri français de la solution colorante noire CESA® IR PE 94000817 proposée par Avient Corporation et utilisée pour colorer des emballages rigides en PE. La solution colorante noire CESA® IR PE 94000817 de Avient Corporation utilisée pour colorer des emballages rigides en PE est une alternative aux solutions colorantes non détectables. En effet, les emballages rigides en PE intégrant 4% de solution colorante noire CESA® IR PE 94000817 sont détectés et orientés vers le flux PE avec les mêmes performances (qualité, taux de captage) que les autres emballages rigides ménagers en PE.

PG 62752.02 RD PE PG05 BLACK PE 802LL STAN-TONE MB-29718 GREEN

272 TRANS LILAC PE STRAWBERRY PE MB STEEL TEX PS

GREEN PE STAN-TONE MB-31022 PEARL PG 44661 PEARL GN PE

UV GREEN MB V2 PE BLUE II PE FIELD GREEN 577C V2

PE PURPLE GRAPE 259C SKY BLUE PE LM STAN-TONE MB-108739 BLACK

Reconciliation of Pro Forma Adjusted Earnings per Share: Nine Months Ended September 30, 2020 Year Ended December 31, 2020 Net income from continuing operations attributable to Avient shareholders $ 57.8 $ 132.0 Special items, after tax 42.0 24.8 Adjusted net income from continuing operations excluding special items 99.8 156.8 Clariant MB pro forma adjustments to net income from continuing operations(2) 20.7 20.7 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 120.5 $ 177.5 Weighted average diluted shares 90.7 90.6 Pro forma impact to diluted shares from January 2020 equity offering(2) 2.9 1.5 Pro forma weighted average diluted shares 93.6 92.1 Adjusted EPS - excluding special items pro forma for Clariant MB acquisition $ 1.29 $ 1.93 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 15 Nine Months Ended September 30, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(2) Pro Forma Adjusted Avient Sales $ 2,245.1 $ — $ 2,245.1 $ 540.5 $ 2,785.6 Operating income $ 124.3 $ 59.1 $ 183.4 $ 45.0 $ 228.4 Interest expense, net (55.3) — (55.3) (18.1) (73.4) Pension settlement gain and mark-to-market adjustment — (6.9) (6.9) — (6.9) Other income, net 12.6 0.3 12.9 — 12.9 Income taxes (22.5) (10.5) (33.0) (6.2) (39.2) Net income attributable to noncontrolling interests (1.3) — (1.3) — (1.3) Net income from continuing operations attributable to Avient shareholders $ 57.8 $ 42.0 $ 99.8 $ 20.7 $ 120.5 Weighted average diluted shares 90.7 Impact to diluted shares from January 2020 equity offering 2.9 Pro forma weighted average diluted shares 93.6 Pro forma adjusted EPS $ 1.29 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 16 Reconciliation of EBITDA by Segment Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Operating income: Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 123.3 Specialty Engineered Materials 31.7 24.7 103.2 64.0 Distribution 23.8 17.5 71.5 51.5 Corporate and eliminations (43.6) (59.2) (109.4) (114.5) Operating income $ 78.7 $ 33.5 $ 307.2 $ 124.3 Items below OI in Corporate: Other income, net $ 1.4 $ 1.5 $ 4.1 $ 12.6 Depreciation & amortization: Color, Additives and Inks $ 26.6 $ 26.3 $ 79.2 $ 48.0 Specialty Engineered Materials 7.9 7.5 23.8 22.7 Distribution 0.2 0.2 0.6 0.4 Corporate and eliminations 2.1 2.5 4.1 6.2 Depreciation & Amortization $ 36.8 $ 36.5 $ 107.7 $ 77.3 EBITDA: Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 171.3 Specialty Engineered Materials 39.6 32.2 127.0 86.7 Distribution 24.0 17.7 72.1 51.9 Corporate and eliminations (41.5) (56.7) (105.3) (108.3) EBITDA $ 116.9 $ 71.5 $ 419.0 $ 214.2 EBITDA as a % of Sales: Color, Additives and Inks 15.9 % 15.6 % 17.6 % 17.5 % Specialty Engineered Materials 17.0 % 18.5 % 18.4 % 16.7 % Distribution 5.5 % 6.4 % 6.0 % 6.4 % 17 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Nine Months Ended September 30, 2020 Sales: Color, Additives and Inks $ 977.1 Clariant MB pro forma adjustments(2) 540.5 Pro forma sales $ 1,517.6 Operating income: Color, Additives and Inks $ 123.3 Clariant MB pro forma adjustments(2) 45.0 Pro forma operating income $ 168.3 Depreciation & amortization: Color, Additives and Inks $ 48.0 Clariant MB pro forma adjustments(2) 30.1 Pro forma depreciation & amortization $ 78.1 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Color, Additives and Inks $ 171.3 Clariant MB pro forma adjustments(2) 75.1 Pro forma EBITDA $ 246.4 Pro forma EBITDA as a % of Sales 16.2 % (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Three Months Ended September 30, Nine Months Ended September 30, Reconciliation to EBITDA and Pro Forma Adjusted EBITDA: 2021 2020 2021 2020 Net income from continuing operations – GAAP $ 52.6 $ 2.6 $ 201.7 $ 59.1 Income tax expense 8.5 2.7 51.8 22.5 Interest expense 19.0 29.7 57.8 55.3 Depreciation and amortization from continuing operations 36.8 36.5 107.7 77.3 EBITDA $ 116.9 $ 71.5 $ 419.0 $ 214.2 Special items, before tax 19.9 50.0 36.5 62.0 Interest expense included in special items — (9.6) — (10.1) Depreciation and amortization included in special items (0.9) (1.3) (0.1) (2.5) Adjusted EBITDA $ 135.9 $ 110.6 $ 455.4 $ 263.6 Clariant MB pro forma adjustments(2) — — — 75.1 Pro forma adjusted EBITDA $ 135.9 $ 110.6 $ 455.4 $ 338.7 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition NEWS RELEASE Attachment 1

$0.30 $0.52 2019 PF 2020 Q4 2020 ORGANIC PERFORMANCE 3 Sales $922 $997 2019 PF 2020 +8% Adjusted Operating Income Adjusted EPS $58 $80 2019 PF 2020 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 4 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI 2019PF 2020 +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total 2019 PF 2020 $17 $19 $40 $18 $30 $58 Distribution SEM CAI 2019PF 2020 +38% +45% +58% +6% (3) (3) ($ in millions) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 5 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 6 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. A reconciliation of these measures to their most directly comparable GAAP measures is provided in the tables below. 1 Reconciliation of EBITDA by Segment Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Sales: Color, Additives and Inks $ 525.8 $ 226.7 $ 1,502.9 $ 1,003.8 Specialty Engineered Materials 190.6 177.5 708.8 745.7 Distribution 305.1 272.4 1,110.3 1,192.2 Corporate and eliminations (24.5) (18.0) (79.9) (79.0) Sales $ 997.0 $ 658.6 $ 3,242.1 $ 2,862.7 Operating income: Color, Additives and Inks $ 57.5 $ 27.2 $ 180.8 $ 147.4 Specialty Engineered Materials 30.4 18.8 94.4 83.7 Distribution 18.0 17.0 69.5 75.4 Corporate and eliminations (40.9) (42.5) (155.4) (149.7) Operating Income $ 65.0 $ 20.5 $ 189.3 $ 156.8 Items Below Operating Income in Corporate: Other income, net $ 11.7 $ 10.7 $ 24.3 $ 12.1 Depreciation & amortization: Color, Additives and Inks $ 27.3 $ 10.7 $ 75.1 $ 42.7 Specialty Engineered Materials 7.4 7.0 30.0 29.5 Distribution 0.3 0.1 0.7 0.5 Corporate and eliminations 2.8 1.0 9.3 5.4 Depreciation & Amortization $ 37.8 $ 18.8 $ 115.1 $ 78.1 EBITDA: Color, Additives and Inks $ 84.8 $ 37.9 $ 255.9 $ 190.1 Specialty Engineered Materials 37.8 25.8 124.4 113.2 Distribution 18.3 17.1 70.2 75.9 Corporate and eliminations (26.4) (30.8) (121.8) (132.2) EBITDA $ 114.5 $ 50.0 $ 328.7 $ 247.0 EBITDA as a % of sales: Color, Additives and Inks 16.1 % 16.7 % 17.0 % 18.9 % Specialty Engineered Materials 19.8 % 14.5 % 17.6 % 15.2 % Distribution 6.0 % 6.3 % 6.3 % 6.4 % Corporate and eliminations nm nm nm nm Total Company 11.5 % 7.6 % 10.1 % 8.6 % nm - not meaningful 2 Three Months Ended December 31, Year Ended December 31, Reconciliation to Adjusted EBITDA: 2020 2019 2020 2019 Net income from continuing operations – GAAP $ 74.7 $ 6.4 $ 133.8 $ 75.7 Income tax expense (17.3) 12.9 5.2 33.7 Interest expense 19.3 11.9 74.6 59.5 Depreciation and amortization from continuing operations 37.8 18.8 115.1 78.1 EBITDA $ 114.5 $ 50.0 $ 328.7 $ 247.0 Special items, before tax 4.2 15.0 66.2 61.7 Interest expense included in special items — — (10.1) — Accelerated depreciation included in special items (0.7) — (3.2) — Adjusted EBITDA $ 118.0 $ 65.0 $ 381.6 $ 308.7 Three Months Ended December 31, 2020 Reconciliation of Adjusted Earnings per Share: Avient Special Items Adjusted Avient Sales $ 997.0 $ — $ 997.0 Operating income $ 65.0 $ 14.6 $ 79.6 Interest expense, net (19.3) — (19.3) Other income, net 11.7 (10.4) 1.3 Income taxes 17.3 (30.9) (13.6) Net income from continuing operations attributable to Avient shareholders $ 74.2 $ (26.7) $ 47.5 Weighted average diluted shares 92.1 Adjusted EPS - excluding special items $ 0.52 Reconciliation of Adjusted EBITDA from continuing operations: Operating income and other income, net $ 76.7 $ 4.2 $ 80.9 Depreciation and amortization 37.8 (0.7) 37.1 EBITDA from continuing operations $ 114.5 $ 3.5 $ 118.0 EBITDA as a % of sales 11.8 % 3 Three Months Ended December 31, 2019 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 658.6 $ — $ 658.6 $ 263.5 $ 922.1 Operating income $ 20.5 $ 24.6 $ 45.1 $ 13.2 $ 58.3 Interest expense, net (11.9) — (11.9) (11.1) (23.0) Other income, net 10.7 (9.6) 1.1 — 1.1 Income taxes (12.9) 4.9 (8.0) (0.5) (8.5) Net income from continuing operations attributable to Avient shareholders $ 6.4 $ 19.9 $ 26.3 $ 1.6 $ 27.9 Weighted average diluted shares 77.5 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 92.8 Pro forma adjusted EPS $ 0.30 Reconciliation of Pro Forma Adjusted EBITDA from continuing operations: Operating income and other income, net $ 31.2 $ 15.0 $ 46.2 $ 13.2 $ 59.4 Depreciation and amortization 18.8 — 18.8 15.1 33.9 EBITDA from continuing operations $ 50.0 $ 15.0 $ 65.0 $ 28.3 $ 93.3 EBITDA as a % of sales 10.1 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Year Ended December 31, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5 Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0 Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6) Other income, net 24.3 (17.6) 6.7 — 6.7 Income taxes (5.2) (41.4) (46.6) (6.2) (52.8) Net income attributable to noncontrolling interests (1.8) — (1.8) — (1.8) Net income from continuing operations attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January 2020 equity offering 1.5 Pro forma weighted average diluted shares 92.1 Pro forma adjusted EPS $ 1.93 Reconciliation of Pro Forma Adjusted EBITDA from continuing operations: Operating income and other income, net $ 213.6 $ — $ 56.1 $ 269.7 $ 45.0 $ — $ 314.7 Depreciation and amortization 115.1 (3.2) 111.9 30.1 142.0 EBITDA from continuing operations $ 328.7 $ 52.9 $ 381.6 $ 75.1 $ 456.7 EBITDA as a % of sales 12.1 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 4 Year Ended December 31, 2019 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3 Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4 Interest expense, net (59.5) — (59.5) (33.4) (92.9) Other income, net 12.1 (10.0) 2.1 — 2.1 Income taxes (33.7) (5.9) (39.6) (9.1) (48.7) Net income attributable to noncontrolling interests (0.2) — (0.2) — (0.2) Net income from continuing operations attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7 Weighted average diluted shares 77.7 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 93.0 Pro forma adjusted EPS $ 1.74 Reconciliation of Pro Forma Adjusted EBITDA from continuing operations: Operating income and other income, net $ 168.9 $ — $ 61.7 $ 230.6 $ 72.9 $ — $ 303.5 Depreciation and amortization 78.1 — 78.1 60.3 138.4 EBITDA from continuing operations $ 247.0 $ 61.7 $ 308.7 $ 133.2 $ 441.9 EBITDA as a % of sales 11.1 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Three Months Ended March 31, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 711.5 $ — $ 711.5 $ 279.4 $ 990.9 Operating income 52.8 9.7 62.5 23.0 85.5 Interest expense, net (9.4) — (9.4) (12.8) (22.2) Other income, net 1.6 (0.1) 1.5 — 1.5 Income taxes (11.9) (1.0) (12.9) (2.4) (15.3) Net income from continuing operations attributable to Avient shareholders $ 33.1 $ 8.6 $ 41.7 $ 7.8 $ 49.5 Weighted average diluted shares 86.7 Impact to diluted shares from January 2020 equity offering 6.1 Pro forma weighted average diluted shares 92.8 Pro forma adjusted EPS $ 0.53 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 5 Three Months Ended December 31, 2019 Year Ended December 31, 2019 Reconciliation of pro forma sales, operating income, and EBITDA: CAI Clariant MB Pro Forma Adjustments(1) Pro Forma CAI CAI Clariant MB Pro Forma Adjustments(1) Pro Forma CAI Sales $ 226.7 $ 263.5 $ 490.2 $ 1,003.8 $ 1,118.6 $ 2,122.4 Operating income $ 27.2 $ 13.2 $ 40.4 $ 147.4 $ 72.9 $ 220.3 EBITDA $ 37.9 $ 28.3 $ 66.2 $ 190.1 $ 133.2 $ 323.3 EBITDA as a % of sales 13.5 % 15.2 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Year Ended December 31, 2020 Reconciliation of pro forma sales, operating income, and EBITDA: CAI Clariant MB Pro Forma Adjustments(1) Pro Forma CAI Sales $ 1,502.9 $ 540.4 $ 2,043.3 Operating income $ 180.8 $ 45.0 $ 225.8 EBITDA $ 255.9 $ 75.1 $ 331.0 EBITDA as a % of sales 16.2 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Free cash flow, defined as cash provided by operating activities excluding items associated with acquisitions and divestitures, less capital expenditures, is considered a non-GAAP financial measure.

TRANS PINK 1593 MB TRANS PLUM 1027 MB MEDIUM GREEN PE